DSDaniel James Stubbs

Daniel James Stubbs

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniel James Stubbs has a total of 304 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Need for a definitive trial of local versus general anaesthesia in chronic subdural haematoma; survey and literature review of ongoing trials

    by Daniel J. Stubbs, Conor S. Gillespie, Matthew L. Watson, Basil Nourallah, Caroline M. Phillips, George Gathercole, Jamie Brannigan, Keng Siang Lee, Orla Mantle, Vian Omar, et al.

    Background: Chronic subdural haematoma (cSDH) is a common neurosurgical condition, many patients have significant comorbidity or are living with frailty. Surgery is effective and can be performed under local anaesthesia (with or without sedation) (LAS) or general anaesthesia (GA). Optimal technique for both GA and LAS is poorly defined but similar questions have been explored in other surgical settings. We sought to clarify the breadth of evidence for anaesthetic technique in cSDH surgery, while drawing on relevant literature from other disciplines to understand how a definitive trial of this question could be performed. Materials and methods: We used a combination of review of trial registries, the Cochrane database, and a survey of anaesthetic and neurosurgical practitioners. Results: We identified a paucity of high-quality studies, especially randomised trials, exploring this question. The literature, and survey of anaesthetists and surgeons suggest that LAS may achieve equivalent outcomes, but significant confounding exists in current studies. Registered trials are single centre, and Cochrane reviews in other fields present issues of equipoise, study design, and outcome choice as key challenges in designing a definitive trial. Conclusions: There is significant interest in this topic as evidenced by published and emerging literature and views of anaesthetists and surgeons. No registered trial is multi-centre or draws on challenges identified in similar trials from other disciplines.

  • Open Access

    Days alive and out of hospital after burr-hole drainage for chronic subdural haematoma: a national cohort study using Hospital Episode Statistics in England

    by Daniel Thompson, Adam Wahba, Benjamin Davies, Adam Williams, Peter John Hutchinson, Daniel Stubbs, Adel Helmy, David A Cromwell

    Objectives: The objective of this study was to investigate the utility of the days alive and out of hospital (DAOH) metric within a cohort of patients undergoing burr-hole drainage of a chronic subdural haematoma (CSDH). We evaluate the validity of the DAOH metric in a national CSDH cohort and examine how the DAOH metric compares to its constituent outcomes (mortality and hospital bed days) at an organisational level. Methods: Retrospective cohort study using Hospital Episode Statistics data linked to the national death registry to identify patients who underwent burr-hole drainage of CSDH in English National Health Service neurosurgical units between 1 April 2013 and 31 March 2020. Construct validity was assessed by measuring the patterns of DAOH across categories of known perioperative risk factors. Variation between units in the risk-adjusted values for DAOH, postoperative mortality and days in hospital was explored using funnel plots. Linear regression and logistic regression were used to derive the risk-adjusted rates. Results: Overall, 16 450 patients who underwent at least one burr-hole drainage of CSDH were identified during the time period. The median 30-day DAOH was 16 (IQR, 0–24); the median for the 90-day DAOH was 74 (42–84), and was better at measuring the complete stay associated with the index admission. Worse 90-day DAOH values were associated with older age, increasing comorbidities and greater frailty. Risk-adjusted 90-day DAOH values for neurosurgical units varied more markedly than for its constituent outcomes. Conclusions: The 90-day DAOH looks to be a valid outcome metric for patients undergoing burr-hole drainage for CSDH that is feasible to derive using national hospital data. Future work should explore how to estimate a minimally important clinical difference for DAOH and evaluate its utility as an outcome measure.

  • Open Access

    A systematic review of efforts to predict day of surgery cancellation

    by Thomas Sardesai, Laura Hobbs, Caroline Phillips, Gauri Ang, Tom Bashford, Katharina Kohler, Daniel Stubbs

    BACKGROUND: Day of surgery cancellation (DOSC) for elective surgery occurs in 18% of elective surgeries worldwide with resultant impacts on patients and healthcare systems. Accurate prediction of such cancellations could yield significant benefit. OBJECTIVE: This systematic review synthesises evidence to inform future efforts at gold-standard statistical modelling. DESIGN: Systematic review and qualitative synthesis using the ‘Synthesis Without Meta-Analysis’ (SWiM) framework. DATA SOURCES: MEDLINE, Embase, Scopus and Web of Science, 2013–2024 ELIGIBILITY CRITERIA: Studies were considered eligible if they presented the development, validation or update of a model to predict DOSC. Risk of bias for included studies was assessed using the prediction model risk of bias assessment tool (PROBAST). Data was collected on included variables, method of prediction, whether prediction was made at the level of the patient or the system, and training and assessment processes. RESULTS: Literature searching identified 7154 unique studies, 6 of which were included in the final synthesis. These studies encompassed total of 759 337 elective surgical procedures, of which 47 609 were cancellations, across a variety of adult and paediatric surgery. Methods of prediction included logistic regression models, machine learning, and spatial regression models. These used demographic, socioeconomic, comorbidity, surgical, appointment and other factors as predictors. The best discrimination achieved by models in each study, quantified by area under the receiver operator curve, ranged from 0.75 to 0.92 in development and 0.70 to 0.74 in validation datasets. One study demonstrated better calibration at the census tract level of spatial regression models when incorporating local survey data compared with individual-prediction-aggregation models. CONCLUSIONS: Models to predict DOSC identified in this review demonstrated moderate discrimination ability but there was significant heterogeneity between studies and reports of calibration were limited. This review serves as a valuable synthesis of current models to predict DOSC and should serve as a core reference for emerging studies in this field.


  • Open Access

    Peri‐operative management of diabetes mellitus: a multidisciplinary consensus statement from the Association of Anaesthetists and the Joint British Diabetes Societies for Inpatient Care group

    by Nicholas A. Levy, Kariem El‐Boghdadly, Dileep N. Lobo, Daniel J. Stubbs, Parizad Avari, Donal Buggy, Claire Frank, Kim Howson, Jinty Moffett, Emma Morris, et al.

    Summary: Introduction: Surgery in patients with diabetes mellitus is associated with increased morbidity and mortality compared with those who do not have diabetes mellitus. This is likely multifactorial and could be attributed to organisational issues; dysglycaemia; hospital‐acquired diabetic ketoacidosis; errors with insulin prescribing and administration; issues with fluids and electrolytes; and systemic and surgical site infections. There was a need to update guidance for the peri‐operative management of diabetes mellitus given improvements in our understanding, introduction of novel drugs and development of wearable technologies. Methods: This was a multidisciplinary consensus statement with a diverse authorship group, including diabetologists; anaesthetists; surgeons; pharmacists; surgical diabetes inpatient specialist nurses; and patients with lived experience. We undertook a directed literature search and a three‐round Delphi process to develop, refine and agree recommendations. Results: Following three rounds, 38 recommendations were included, spanning all phases of the peri‐operative pathway. Recommendations were made for organisations and general principles for the management of patients with diabetes, aiming to improve pathways, implement protocols and support training. We prioritise individualised care plans, encourage clinical judgement regarding proceeding with surgery with out‐of‐range HbA1c concentrations and recommend ensuring appropriate insulin regimens are prescribed and administered. We also provide guidance for capillary blood glucose and ketone monitoring and management; safe handovers of care; and multidisciplinary care plans for the peri‐operative use of wearables. Discussion: This consensus statement provides principles to be applied throughout the entire peri‐operative pathway by healthcare professionals, institutions and patients. It is hoped that the implementation of these key recommendations will improve experience and outcomes for patients with diabetes mellitus having surgery.


  • Open Access

    Chronic subdural haematoma: a UK cost description analysis

    by Joseph Dulleston, Garry Barton, Benjamin M. Davies, Alexis J. Joannides, Adel Helmy, Peter Hutchinson, Daniel J. Stubbs

    Chronic subdural haematoma (cSDH) is a prevalent neurosurgical condition with an increasing incidence. Most cSDH occur in patients with complex perioperative needs and emerging clinical practice guidelines could provide substantial benefit. This study sought to understand current and future health service costs to inform guideline implementation. Using data from the Cambridge University Hospital neurosurgical network, national audit reports, and UK unit cost data, we modelled the total national cost of operative cSDH treatment in 5-year intervals to 2040. Estimates were adjusted for inflation (2.5%) and demographic change (Office for National Statistics). We also modelled potential savings from reductions in hospital length of stay (5 - 40%) and post-discharge care costs (2.5 - 10%). In 2025, operative cSDH is estimated to cost £15,100 per case and £42,150,000 across the UK, rising by 45% and 88% by 2040, respectively. A 20% reduction in neurosciences unit length-of-stay and 5% reduction in post-discharge costs could save £1,220 per case and £3,395,000 UK wide in 2025. This will rise approximately two-fold by 2040. cSDH has a significant, and increasing, economic impact. Implementing integrated multidisciplinary care could yield monetary savings as well as additional benefits, such as increased operative capacity.


  • Open Access

    Early Mobilization in Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis

    by Usama AlDallal, Munashe Veremu, Sean O'LEary, William H. Cook, Youssef Chedid, Alex Henney, Mohammad Ashraf, David Quist, Vian Omar, Adele Mazzoleni, et al.


  • Open Access

    Need for a definitive trial of local versus general anaesthesia in chronic subdural haematoma; lessons from a systematic review, survey, and scoping review of other surgical conditions

    by Daniel J. Stubbs, Conor S. Gillespie, Matthew L. Watson, Basil Nourallah, Caroline M Phillips, George Gathercole, Jamie Brannigan, Keng Siang Lee, Orla Mantle, Vian Omar, et al.

    Background: Chronic subdural haematoma (cSDH) is a common neurosurgical condition, many patients have significant comorbidity or are living with frailty. Surgery is effective and can be performed under local anaesthesia (with or without sedation) or general anaesthesia. Optimal technique for both GA and LA is poorly defined but similar questions have been explored in other surgical settings. We sought to clarify the breadth of evidence for anaesthetic technique in cSDH surgery, while drawing on relevant literature from other disciplines to understand how a definitive trial of this question could be performed. Materials and Methods: We used a combination of systematic and narrative literature search, review of trial registries, the Cochrane database, and a survey of anaesthetic and neurosurgical practitioners. An updated systematic review and meta-analysis of trial and observational studies in this area was performed following PROSPERO registration. Results: We identified a paucity of high-quality studies, especially randomised trials, exploring this question. The literature, and a survey of anaesthetists and surgeons, suggest that local anaesthesia may bring benefits in shorter hospital stay and reduced complications. Registered studies in this field are single centre in nature while a synthesis of Cochrane reviews in other fields echoes issues of equipoise, study design, and outcome choice as key challenges in designing a definitive trial. Conclusions: There is significant interest in this topic as evidenced by published and emerging literature and views of anaesthetists and surgeons. No registered trial is multi-centre or draws on challenges identified in similar trials from other disciplines. Our paper helps create a roadmap to a definitive trial of this crucial question.

  • Time to resumption of antithrombotic therapy in chronic subdural haematoma: a systematic review and meta-analysis

    by Adele Mazzoleni, Jamie F. M. Brannigan, Munashe Veremu, Youssef Chedid, William H. Cook, Matthew L. Watson, Keng Siang Lee, Orla Mantle, Vian Omar, Marwan Al-Munaer, et al.

    Chronic subdural haematoma (CSDH) is common in the elderly, with approximately 40% of patients with CSDH taking anti-thrombotic medications. Surgery necessitates temporary cessation. The optimal time of postoperative antithrombotic resumption is not known, with the risk of recurrence balanced against the risk of thrombosis. A systematic review was carried out (registration number:CRD42023427275). Medline and EMBASE databases were searched. The primary outcome of this study was recurrence. Late and early resumption was defined by study authors - a final definition was not possible given the heterogeneity amongst papers. 7 studies were included in the final analysis (3,195 patients total). Generally, studies reported higher risk of thromboembolic events in patients in late resumption groups (n = 4). On meta-analysis, there was no increased risk of recurrence in the early vs late groups (OR 0.61, 95% CI [0.016; 2.40], I2 = 0%, p = 0.26). Most studies reported that early resumption was not associated with increased adverse events. Definitions of early and late varied by study (earliest range <3 days to <30 days). We found no significant difference in rates of recurrence, or thromboembolic events in those receiving early or late resumption of antithrombotic medication. Prospective studies with consensus definitions are required to inform clinical decision making and guidelines.


  • Open Access

    Non-insulin diabetes medicines: a narrative review for anaesthetists and intensivists

    by Sarah Tinsley, Claire Frank, Daniel Stubbs, Ketan Dhatariya, Roger D. Knaggs, Nicholas A. Levy


  • Open Access

    Development of insulin and its pharmacology and perioperative use: a narrative review

    by Ketan Dhatariya, Nicholas A. Levy, Daniel Stubbs, Claire Frank, Sarah L. Tinsley, Roger D. Knaggs